The 36-month beta value for NUS is at 1.14. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 2 rating it as “overweight,” 1 as “hold,” and 1 as “sell.”
The public float for NUS is 48.71M, and currently, shorts hold a 3.76% of that float. The average trading volume for NUS on June 26, 2024 was 686.61K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NUS) stock’s latest price update
Nu Skin Enterprises, Inc. (NYSE: NUS) has experienced a decline in its stock price by -7.04 compared to its previous closing price of 11.51. However, the company has seen a fall of -12.51% in its stock price over the last five trading days. zacks.com reported 2024-06-20 that Nu Skin (NUS) has been battling persistent macroeconomic headwinds across most regions, which has affected customer and affiliate acquisition.
NUS’s Market Performance
Nu Skin Enterprises, Inc. (NUS) has experienced a -12.51% fall in stock performance for the past week, with a -19.18% drop in the past month, and a -14.40% drop in the past quarter. The volatility ratio for the week is 5.21%, and the volatility levels for the past 30 days are at 3.45% for NUS. The simple moving average for the past 20 days is -17.31% for NUS’s stock, with a -34.36% simple moving average for the past 200 days.
Analysts’ Opinion of NUS
Many brokerage firms have already submitted their reports for NUS stocks, with Jefferies repeating the rating for NUS by listing it as a “Hold.” The predicted price for NUS in the upcoming period, according to Jefferies is $39 based on the research report published on January 31, 2023 of the previous year 2023.
BofA Securities gave a rating of “Neutral” to NUS, setting the target price at $58 in the report published on October 02nd of the previous year.
NUS Trading at -16.56% from the 50-Day Moving Average
After a stumble in the market that brought NUS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -68.82% of loss for the given period.
Volatility was left at 3.45%, however, over the last 30 days, the volatility rate increased by 5.21%, as shares sank -19.18% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.20% lower at present.
During the last 5 trading sessions, NUS fell by -12.51%, which changed the moving average for the period of 200-days by -53.38% in comparison to the 20-day moving average, which settled at $12.81. In addition, Nu Skin Enterprises, Inc. saw -44.90% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NUS starting from LIPMAN ANDREW D, who sale 2,000 shares at the price of $13.33 back on May 28 ’24. After this action, LIPMAN ANDREW D now owns 23,225 shares of Nu Skin Enterprises, Inc., valued at $26,660 using the latest closing price.
WOODBURY EDWINA D, the Director of Nu Skin Enterprises, Inc., sale 1,693 shares at $12.02 during a trade that took place back on May 02 ’24, which means that WOODBURY EDWINA D is holding 18,095 shares at $20,350 based on the most recent closing price.
Stock Fundamentals for NUS
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.68 for the gross margin
The net margin for Nu Skin Enterprises, Inc. stands at -0.0. The total capital return value is set at 0.04. Equity return is now at value -0.39, with -0.19 for asset returns.
Based on Nu Skin Enterprises, Inc. (NUS), the company’s capital structure generated 0.37 points at debt to capital in total, while cash flow to debt ratio is standing at 0.3. The debt to equity ratio resting at 0.6. The interest coverage ratio of the stock is 9.94.
Currently, EBITDA for the company is 137.66 million with net debt to EBITDA at 3.11. When we switch over and look at the enterprise to sales, we see a ratio of 0.46. The receivables turnover for the company is 28.42for trailing twelve months and the total asset turnover is 1.09. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.09.
Conclusion
In conclusion, Nu Skin Enterprises, Inc. (NUS) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
